Starting diabetes medicine sooner after kidney injury may protect kidneys

edited by Gaby Clark , reviewed by Robert Egan

This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:

Add as preferred source After propensity-score matching, adverse kidney events were recorded in 3.9% of patients who started SGLT-2 inhibitors within 30 days after discharge, compared with 6.2% of those who started 31-90 days after discharge. Credit: National Taiwan University A study of adults with type 2 diabetes recovering from dialysis-requiring acute kidney injury found that patients who began an SGLT-2 inhibitor within 30 days of hospital discharge had fewer serious kidney events than those who started the medicine 31 to 90 days after discharge. The research, led by National Taiwan University Hospital and published in JAMA Network Open , examines an important question about treatment during kidney recovery.